We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+11.37%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$522B
AUM Growth
+$107B
Cap. Flow
+$36.2B
Cap. Flow %
6.94%
Top 10 Hldgs %
33.87%
Holding
11,604
New
1,567
Increased
4,405
Reduced
4,403
Closed
1,138

Sector Composition

Rank Sector Weight
1 Technology 1.99%
2 Consumer Discretionary 1.08%
3 Financials 1%
4 Communication Services 0.82%
5 Healthcare 0.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTK icon
10276
PUT
Flotek Industries
FTK
$874M
$30K ﹤0.01%
+1,850
New +$21.6K
KOPN icon
10277
CALL
Kopin
KOPN
$898M
$30K ﹤0.01%
21,700
-129,600
-86% -$200K
MLSS icon
10278
Milestone Scientific
MLSS
$42.6M
$30K ﹤0.01%
+21,382
New +$37.3K
SM icon
10279
SM Energy
SM
$8.54B
$30K ﹤0.01%
19,026
-792,529
-98% -$2.21M
KA
10280
CALL
DELISTED
Kineta, Inc. Common Stock
KA
$30K ﹤0.01%
194
+97
+100% +$18.2K
ELVT
10281
DELISTED
Elevate Credit, Inc.
ELVT
$30K ﹤0.01%
+11,643
New +$24.7K
LFT
10282
Lument Finance Trust
LFT
$36.9M
$29K ﹤0.01%
+10,741
New +$26.5K
RMTI icon
10283
Rockwell Medical
RMTI
$31.5M
$29K ﹤0.01%
243
-46
-16% -$7.96K
RNAC icon
10284
Cartesian Therapeutics
RNAC
$325M
$29K ﹤0.01%
+395
New +$30.3K
TRIB
10285
Trinity Biotech
TRIB
$8.09M
$29K ﹤0.01%
95
-22
-19% -$7.64K
VSA
10286
VisionSys AI
VSA
$10.1M
$29K ﹤0.01%
+7
New +$29.7K
DMK
10287
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$29K ﹤0.01%
+530
New +$31.4K
TMQ
10288
Trilogy Metals
TMQ
$665M
$28K ﹤0.01%
15,526
-2,338
-13% -$4.64K
VIRC icon
10289
Virco
VIRC
$93.6M
$28K ﹤0.01%
+12,919
New +$29.7K
SRGA
10290
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$28K ﹤0.01%
514
-451
-47% -$34.5K
SBBP
10291
DELISTED
Strongbridge Biopharma plc.
SBBP
$28K ﹤0.01%
+13,391
New +$45.1K
TDAY
10292
PUT
USA Today Co
TDAY
$919M
$27K ﹤0.01%
20,800
-9,000
-30% -$13.7K
NML
10293
Neuberger Energy Infrastructure and Income Fund Inc
NML
$589M
$27K ﹤0.01%
+11,401
New +$31K
PBT
10294
CALL
Permian Basin Royalty Trust
PBT
$1.63B
$27K ﹤0.01%
10,800
-400
-4% -$1.23K
SD icon
10295
PUT
SandRidge Energy
SD
$515M
$27K ﹤0.01%
16,500
+3,300
+25% +$5.17K
TOUR
10296
Tuniu
TOUR
$52.5M
$27K ﹤0.01%
2,299
+1,289
+128% +$14.4K
TPST icon
10297
PUT
Tempest Therapeutics
TPST
$17.9M
$27K ﹤0.01%
84
+15
+22% +$5.09K
VIRX
10298
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$27K ﹤0.01%
+6,086
New +$53.2K
BKEP
10299
PUT
DELISTED
Blueknight Energy Partners L.P.
BKEP
$27K ﹤0.01%
+17,500
New +$25.8K
AIRI icon
10300
Air Industries Group
AIRI
$11.9M
$26K ﹤0.01%
+2,149
New +$26K

Similar funds

Jeff Yass's Q3 2020 Portfolio in Review

As of Q3 2020, Jeff Yass held 11,604 positions worth $522B, up 26% from $415B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass deployed $36.2B of net new capital in Q3 2020, opening 1,567 new positions and adding to 4,405 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,104,687 shares worth $284M.

By sector, the portfolio is most concentrated in Technology at 2% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $3.18B trimmed.

  • Jeff Yass's largest Q3 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,104,687 shares worth $284M.
  • Jeff Yass added most to Apple in Q3 2020, an estimated $2.66B increase.
  • Jeff Yass's biggest Q3 2020 reduction was Invesco QQQ Trust, cutting an estimated $3.18B.
  • Jeff Yass fully exited Vanguard Short-Term Corporate Bond ETF in Q3 2020, selling an estimated $34.1M.
  • Jeff Yass's ten largest holdings make up 34% of its $522B portfolio in Q3 2020.
  • Jeff Yass opened 1,567 new positions and closed 1,138 in Q3 2020.
  • Jeff Yass's portfolio value rose 26% quarter-over-quarter to $522B.

Based on Susquehanna International Group's 13F filing for Q3 2020, filed 16 Nov 2020.